![Laxminarayan Bhat](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laxminarayan Bhat
Gründer bei
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Vermögen: 50 803 $ am 31.05.2026
Profil
Dr. Laxminarayan Bhat is a President, Chief Executive Officer & Director at Reviva Pharmaceuticals Holdings, Inc. and a President, Chief Executive Officer & Director at Reviva Pharmaceuticals, Inc. He is on the Board of Directors at Reviva Pharmaceuticals Holdings, Inc. and Reviva Pharmaceuticals, Inc. Dr. Bhat was previously employed as a Research Scientist by ARYx Therapeutics, Inc. and a Research Scientist by XenoPort, Inc. He received his doctorate degree from North-Eastern Hill University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.03.2026 | 124’213 ( 0.97% ) | 50 803 $ | 31.05.2026 |
Aktive Positionen von Laxminarayan Bhat
| Unternehmen | Position | Beginn |
|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. | Gründer | 11.12.2020 |
Reviva Pharmaceuticals, Inc.
 Reviva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company developing therapies for unmet medical needs in central nervous system, cardiovascular, metabolic and inflammatory diseases | Gründer | 01.01.2006 |
Ehemalige bekannte Positionen von Laxminarayan Bhat
| Unternehmen | Position | Ende |
|---|---|---|
| ARYX THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.01.2006 |
| XENOPORT, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.01.2004 |
Ausbildung von Laxminarayan Bhat
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
15
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Reviva Pharmaceuticals, Inc.
Reviva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company developing therapies for unmet medical needs in central nervous system, cardiovascular, metabolic and inflammatory diseases | Health Technology |
ARYx Therapeutics, Inc.
 ARYx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
North-Eastern Hill University
 North-Eastern Hill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reviva Pharmaceuticals Holdings, Inc.
 Reviva Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for central nervous system, cardio vascular, metabolic and inflammatory diseases | Health Technology |
Wählen Sie MarketScreener 
